WinstonWınston
Back
Stock

Bruker Corporation

BRKRP
27
Medical - Devices · Healthcare
Price
$464.27
+17.20 (+3.85%)
Market Cap
$9.31B
Exchange
NASDAQ
Winston Score
27
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Sep 17, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available
Dividends
Mixed
Track this stock — start free trial

§Winston Score History

The full picture

Bruker makes advanced scientific instruments used by researchers, universities, pharmaceutical companies, and hospitals. Its tools help scientists study molecules, proteins, and materials at a very detailed level. Key products include mass spectrometers, nuclear magnetic resonance (NMR) systems, and X-ray analysis equipment, and Bruker is one of the world's leading makers of NMR instruments.

The company earns revenue by selling high-end instruments and providing ongoing service, maintenance, and consumables contracts. Bruker operates globally, with significant sales across North America, Europe, and Asia, and has a market cap around $9.4 billion. Its deep expertise in precision measurement technology and a large installed base of instruments create meaningful switching costs for customers. A key growth driver is expanding demand for proteomics and spatial biology tools, though the company faces risks from its relatively thin operating margins and its dependence on academic and government research funding cycles.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-920.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$395M/ year

→ Flat (+5% vs prior year)

11.5% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

31.9%ownership

Insiders own a meaningful stake in the company

Cash Runway

~5 months

$185M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Bruker Corporation has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

−0.7% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 152.9M (2021) → 151.8M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
49.6%
Healthy — 49.6% gross margin
Profit after running costs
Operating Margin
-7.8%
Losing money on operations — -7.8%
Return on the money invested
ROCE
2.9%
Weak — 2.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+1.6%
Nearly flat sales (+1.6% YoY)
Profit growth
EPS YoY
-234.4%
Earnings shrinking (-234.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
1/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
2.7%
Thin free cash flow (2.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.80
Moderate — manageable debt (0.80)
Covers its interest
Interest Cover
2.89x
Tight — interest eats into profit (2.9x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.40%
Moderate income — 3.40% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
N/A
—
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial